Barron’s Top Weekend Stock Picks: PayPal, Coinbase, DraftKings And Why Elon Musk, Tesla Are Facing Their Biggest Challenge
Benzinga reviews this weekend's top stories covered by Barron's, here are the articles investors need to read.
Bulls And Bears Of The Week: Apple, Meta, Tesla, Carvana And Why It’s Bullish To Keep Dogecoin And Twitter Apart
Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top stories.
As A Water Crisis Threatens The Globe, These 3 Dividend Paying Water Utilities Could See Their Market Caps Balloon
The Invesco Water Resources ETF (NASDAQ: PHO) is down approximately 21% year-to-date, compared to the S&P 500 which is down roughly 22% year-to-date.
With Over 30 LNG Tankers Waiting Off The Coast Of Europe, US Gas Transporters Could Benefit From Contango
More than 30 natural gas tankers carrying liquified natural gas (LNG) are idling, reported the Wall Street Journal, and slowing their routes off Europe’s coast, waiting for the price of fuel to rise.
Lilly-Boehringer Partnered Jardiance Slows Kidney Disease Progression, Data Shows
Boehringer Ingelheim and Eli Lilly And Co (NYSE:LLY) said their diabetes drug Jardiance showed to slow the progression of chronic kidney disease.…
Illumina’s Q3 Profits Hit By Impairment Of Almost $4B, Cuts Annual Guidance
Illumina Inc (NASDAQ:ILMN) posted Q2 revenue of $1.12 billion, up 1% Y/Y and up 3% on a constant currency basis,…
Europe Approves AstraZeneca-Sanofi Partnered Antibody To Prevent RSV Infection In Infants
The European Commission has approved AstraZeneca plc (NASDAQ:AZN) and Sanofi SA’s (NASDAQ:SNY) Beyfortus (nirsevimab) long-acting antibody to prevent respiratory syncytial virus (RSV) lower…
Insulet Shares Jump After Q3 Earnings Surpass Expectations, Improved Annual Guidance
Insulet Corp (NASDAQ:PODD) posted an adjusted EPS of $0.45 in Q3, surpassing the consensus of $0.15. Insulet recorded a bottom-line…
Pfizer, BioNTech Launch Omicron-Adapted COVID Shot-Flu Combination Vaccine Study
Pfizer Inc (NYSE:PFE) and its German partner BioNTech SE (NASDAQ:BNTX) have started an early-stage study to evaluate a combination vaccine targeting COVID-19…